ALTSTATION.IO

Altria Group, Inc. (MO) Stock Analysis

By Nova Skye | AltStation.io | Updated February 07, 2026

Price

$65.26

Change

-0.20%

Market Cap

$109.55B

Avg Volume

9.8M

Company Overview

Altria Group, Inc. manufactures and sells various tobacco products in the United States. Its product lineup includes cigarettes, with Marlboro as its flagship brand, along with large cigars and pipe tobacco under Black & Mild. The company also offers smokeless tobacco products like Copenhagen and Skoal, as well as oral nicotine pouches through its on! brand. Altria’s customers primarily include distributors and large retail chains.

Altria holds a dominant position in the U.S. tobacco market, regarded as a market leader thanks to its strong Marlboro brand and extensive distribution networks. The company faces competition from rivals like Reynolds American and Liggett Group, which challenge its market share. Regulatory pressure and shifting consumer preferences towards reduced-risk products, such as e-vapor, pose threats, but Altria’s investment in these areas gives it a competitive edge.

Currently, Altria is in a transitional phase, adapting to the declining cigarette sales while exploring new product lines. The company’s recent acquisition of NJOY, a e-vapor brand, marks a strategic shift towards the growing non-combustible segment of the market. Despite past struggles with regulatory hurdles and market volatility, Altria remains focused on repositioning itself for sustainable growth in a changing landscape.

Key Financials

Market Cap

$109.55B

Revenue

$20.14B

EBITDA

$12.51B

Gross Margin

72.3%

Profit Margin

34.5%

Revenue Growth

-0.5%

Total Cash

$4.47B

Total Debt

$25.71B

Free Cash Flow

N/A

52-Week Price Performance Analysis

Price Statistics

P/E Ratio

15.84

Forward P/E

11.25

Beta

0.50

52-Week High

$68.60

52-Week Low

$52.40

EPS

$4.12

50-Day Avg

$59.47

200-Day Avg

$61.08

Price/Book

-31.25

Technical Analysis

Over the past 52 weeks, Altria Group, Inc. (MO) has demonstrated a strong upward trend, increasing from around $50 to the current price of $65.26, reflecting a 30.2% gain. Key support is established at $50, as seen during the dips earlier in the year, while resistance is evident at approximately $65.40, where the stock faced challenges in January and February. The chart displays a bullish consolidation pattern that contributed to the acceleration in price over the last few weeks, with noticeable increases after breaking through previously established resistance levels. Recent momentum has been particularly robust, characterized by higher lows and higher highs, indicating strong buying activity. The current price is positioned near the upper end of the 52-week range, suggesting continued upward potential if the stock can maintain momentum above $65.40.

Recent News and Developments

Here’s a summary of the latest news and developments for Altria Group, Inc

(MO) stock over the past week:

Market Update

### Altria Projects 2026 Earnings Growth
Altria Group (MO) has provided its outlook for the 2026 full-year adjusted diluted earnings per share (EPS), projecting a range between $5.56 and $5.72. This forecast represents a growth rate of 2.5% to 5.5% from the anticipated 2025 base EPS of $5.42. The company expects this EPS growth to be more significant in the latter half of 2026, driven by an antici

Market Update

### Mixed Analyst Sentiment and Recent Price Target Adjustments
Analyst sentiment regarding Altria Group (MO) has been mixed but included some positive adjustments recently. UBS upgraded Altria Group to a “Buy” rating from “Neutral” on January 9, 2026, and adjusted its price target to $63 from $61. Meanwhile, Stifel trimmed its price target from $72 to $68 around February 1, 2026, but maintained a

Market Sentiment and Analyst Recommendations

Bull Case

Altria trades at a 15.84 P/E with a 109.5 billion dollar market cap and generates 20.14 billion in annual revenue, making it a cash machine in a mature but stable industry. The company projects 2.5% to 5.5% EPS growth for 2026 on a 5.42 dollar base, which is modest but real in a declining cigarette category. The stock has rallied 30.2% off its 50 dollar low and just broke through 65.40 resistance, suggesting institutional accumulation is underway. UBS upgraded to buy in January and raised its target to 63 dollars, while Stifel kept a buy rating despite trimming from 72 to 68, indicating conviction among the analyst community. The smoke-free pivot is gaining traction with on! PLUS expanding into three states and the FDA filing for the Ploom device representing a legitimate long-term diversification play. At 65.26, the stock sits near fair value on consensus estimates and offers a higher-yielding alternative to the broader market with less duration risk.

Bear Case

Revenue is contracting at negative 0.5%, which is the real problem here, not the headline earnings growth. Altria carries 25.71 billion in debt against only 4.47 billion in cash, leaving limited financial flexibility if margins compress or the dividend becomes unsustainable. The smoke-free products are still experimental and unproven at scale, while NJOY ACE is explicitly not returning in 2026, signaling setbacks in the transition strategy. The stock is already at the top of its 52-week range and near analyst resistance at 65.40, meaning upside is capped and downside risk is asymmetric if the 2026 EPS guidance misses. Regulatory risk is endemic to tobacco, and the FDA filing delays on Ploom show the company cannot control its own product timeline. The valuation is fair, not cheap, which leaves no margin of safety if execution stumbles.

What to Watch

Monitor the 2026 EPS actuals against the 5.56 to 5.72 dollar guidance range, particularly the second-half acceleration the company promised on import-export activity. Watch for FDA decision timing on the Ploom application and any commentary on on! PLUS adoption rates in the three pilot states, as these are the only real growth levers left. Track quarterly revenue trends to see if the negative 0.5% growth rate stabilizes or worsens, since that’s the biggest red flag on the fundamental story. The stock needs to hold above 65.40 resistance to maintain momentum, but failure to break above 68 by mid-year would suggest the rally is exhausted. Pay attention to dividend sustainability and any debt reduction announcements, since the 25.71 billion debt load is the leverage point that could force a cut if cash flow deteriorates. Finally, monitor analyst estimate revisions monthly, since the Zacks estimate ticked up slightly to 5.57 dollars but could move sharply if guidance becomes questionable.

Analyst Consensus

BUY

Based on 12 analyst opinions

Low Target

$47.00

Mean Target

$62.58

High Target

$73.00

Earnings and Financial Data

Sector

Consumer Defensive

Industry

Tobacco

Employees

N/A

Earnings & Dividends

Next Earnings

Apr 30, 2026

EPS (Trailing)

$4.12

Dividend Yield

648.0%

Payout Ratio

101.0%

Frequently Asked Questions

Is MO a good stock to buy?

Altria Group (MO) currently holds a “BUY” recommendation from analysts with a target price of $62.58. Given its competitive P/E of 15.84 and robust dividend yield, it’s worth considering for income-focused investors.

What is MO’s price target?

Analysts have set a price target of $62.58 for MO. This suggests a potential downside from the current price of $65.26, indicating some caution in the short term.

Does MO pay a dividend?

Yes, MO boasts an impressive dividend yield of 648.0%. This high yield makes it attractive for income-seeking investors who prioritize dividends.

What is the 52-week price range for MO?

MO has traded between $52.40 and $68.60 over the past year. This range indicates some volatility, but also highlights the stock’s potential for capital appreciation.

How does MO’s valuation compare to its earnings?

With a forward P/E of 11.25, MO is positioned favorably against its trailing P/E of 15.84. This suggests that the stock may be undervalued relative to its future earnings potential, presenting a compelling case for investment.

Related Stock Reports

Disclaimer: This report is for informational purposes only and does not constitute financial advice. The analysis and opinions expressed are those of AltStation.io and should not be relied upon as the sole basis for investment decisions. Always conduct your own research and consult with a qualified financial advisor before making investment decisions. Past performance does not guarantee future results. Updated February 07, 2026.